16 September 2015
Melbourne IVF achieve new birth success from ovarian tissue grafting and IVF
Melbourne IVF today announced their second success achieving a pregnancy and birth from world leading treatment with ovarian tissue grafted into the abdominal and pelvic walls of a woman who had been left infertile after cancer treatment.
Jodie, from Traralgon in country Victoria, gave birth to a healthy girl at Waverley Private Hospital after seeking ovarian tissue grafting to help her regain fertility following treatment for lymphoma cancer.
Melbourne IVF and the Royal Women’s Hospital achieved the world’s first births from abdominal wall grafting – twin girls – in 2013 from this technology when a Melbourne woman, Vali, became pregnant seven years after her ovaries were removed during cancer treatment and fragments of ovarian tissue were stimulated to produce eggs that were fertilised through IVF. Two embryos were created and inserted into the woman’s pelvis resulting in the world first pregnancy and the babies’ arrival in November 2013.
Speaking at the annual scientific meeting of the Fertility Society of Australia in Canberra, Assoc.Prof. Stern said: “We have been thrilled with the outcome of beautiful twins from our first successful grafting procedure, and delighted to now have a gorgeous new baby born from this procedure”.
Dr Haider Najjar, Melbourne IVF fertility specialist and managing obstetrician, delivered the baby at Waverley Private Hospital. “While this baby’s conception was a complex journey, the ante natal care was normal and the delivery encounters were obstetrically routine,” he said.
“It was a privilege to care for this family and it is incredibly reassuring for other women facing oncology treatment that today’s science can give them fertility options for a family of their own” Dr Najjar said.
Assoc. Prof. Stern added: “This success confirms that ovarian tissue grafting provides a realistic opportunity for women to have a baby after being treated for cancer that leaves them infertile because of the surgical removal of reproductive organs or the toxic effects of some therapy.
She said the latest case was further evidence to support ovarian tissue grafting. Once an egg is produced and fertilised through IVF, the embryo can be transferred into the pelvis for pregnancy to proceed.
“While adult women may sometimes have the opportunity to freeze eggs prior to cancer treatment for fertility preservation, ovarian tissue freezing is the only option for pre-pubertal girls,” she explained.
Jodie and Aden, the couple from Traralgon, said today: “We are so fortunate to have been referred for fertility preservation prior to cancer treatment. What we thought was impossible was made a reality and our baby girl, Evie, has made our lives complete. Words can't express just how grateful we are for our special little miracle.”
Assoc. Prof. Stern said improvements in cancer therapy had resulted in long-term survival from many malignancies, but a significant proportion of patients are left infertile because of the treatment.
“Our scientific team, led by Dr Debra Gook, is working on strategies to further improve the ovarian tissue grafting technique. “Meanwhile, the increasing success with the grafting procedure provides real optimism for cancer patients to achieve their dreams of parenthood."
Melbourne IVF has been involved in extensive research for more than 20 years on ways to protect and preserve fertility in women and men who need treatment for cancer, with cancer specialists and the Reproductive Services Unit at the Royal Women's Hospital.
We are currently developing new ways to help protect fertility during chemotherapy or other therapies that can affect the reproductive organs. Our research focuses on techniques to preserve mature eggs or ovarian tissue before chemotherapy, radiotherapy or surgery.
Learn more about female fertility preservation